A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)

被引：0
|
作者：
Kuhlmann, J. D. [1 ,2 ]
Klotz, B. M. [1 ,2 ]
Link, T. [1 ,2 ]
Wimberger, P. [1 ,2 ]
机构：
[1] Tech Univ Dresden, Dept Gynecol & Obstet, Med Fac, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1769870
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
61
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [41] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
    Vincent Dochez
    Hélène Caillon
    Edouard Vaucel
    Jérôme Dimet
    Norbert Winer
    Guillaume Ducarme
    Journal of Ovarian Research, 12
  • [42] Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer
    Wang, Yingmei
    Han, Cha
    Teng, Fei
    Bai, Zhaoyi
    Tian, Wenyan
    Xue, Fengxia
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (01) : 58 - 63
  • [43] Measuring HE4 alongside CA125 for ovarian cancer diagnosis: A pilot clinical study
    Crawford, S. Michael
    Evans, Colin
    Shaw, Alison
    Barr, Chloe E.
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (12) : 1725 - 1726
  • [44] The diagnostic performance of the Mindray system in detecting CA125 and HE4 for patients with ovarian cancer
    Feng, Pingfeng
    Chen, Tao
    Wischhusen, Joerg
    Ladbury, Colton
    Vargas-Hernandez, Victor Manuel
    Xiong, Yufeng
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08)
  • [45] Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer
    Sandhu, Noreen
    Karlsen, Mona A.
    Hogdall, Claus
    Laursen, Inga A.
    Christensen, Ib J.
    Hogdall, Estrid V. S.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (06): : 477 - 484
  • [46] Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer
    Lowe, Kimberly A.
    Shah, Chirag
    Wallace, Erin
    Anderson, Garnet
    Paley, Pamela
    McIntosh, Martin
    Andersen, M. Robyn
    Scholler, Nathalie
    Bergan, Lindsay
    Thorpe, Jason
    Urban, Nicole
    Drescher, Charles W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (09) : 2480 - 2487
  • [47] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
    Dochez, Vincent
    Caillon, Helene
    Vaucel, Edouard
    Dimet, Jerome
    Winer, Norbert
    Ducarme, Guillaume
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [48] HE4 antigen-autoantibody complexes complement CA125 for detecting early stage ovarian cancer and can be elevated with CA125 in preclinical ovarian cancer
    Yang, Wei-Lei
    Lu, Zhen
    Lu, Karen H.
    Menon, Usha
    Kobayashi, Makoto
    Hanash, Samir
    Skates, Steven
    Bast, Robert C.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
    Van Gorp, T.
    Cadron, I.
    Despierre, E.
    Daemen, A.
    Leunen, K.
    Amant, F.
    Timmerman, D.
    De Moor, B.
    Vergote, I.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 863 - 870
  • [50] COMPARISON OF HE4, CA125, AND RISK OF OVARIAN MALIGNANCY ALGORITHM IN THE PREDICTION OF OVARIAN CANCER IN KOREAN WOMEN
    Cho, H. Y.
    Sung-ho, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1463 - 1463
12345